by Rajashri on  August 12, 2008 at 5:10 PM Drug News
 FDA Issues Warning on Rare Muscle Injury
The U.S. Food and Drug Administration has warned that patients using a combination of simvastatin and anti-arrhythmia medicine amiodarone could suffer a rare fatal muscle injury.

The injury called rhabdomyolysis may lead to kidney failure or even death.

The FDA said it had already warned about this condition in 2002, but that patients were still being prescribed this combination.

Source: Medindia
RAS/L

Most Popular on Medindia